Which drug is used for short-term management of generalized anxiety (non-psychotic)?

Which drug is used for short-term management of generalized anxiety (non-psychotic)?

• A. Trifluoperazine
• B. Perphenazine + Amitriptyline
• C. Haloperidol
• D. Chlorpromazine, Haloperidol

Answer: (A)

Short-term control of generalized anxiety relies on agents with rapid tranquilizing/sedative effects. Trifluoperazine, a potent phenothiazine, has strong sedative and calming properties due to its dopamine blockade in the limbic system and additional tranquilizing effects (often also through antihistaminic activity). This makes it useful for quick relief of acute anxiety or agitation in non-psychotic states. The other options don’t fit this purpose as well. A combination of an antipsychotic with an antidepressant isn’t standard for short-term anxiety management and adds unnecessary complexity and side effects. A single high-potency antipsychotic like haloperidol can calm anxiety through sedation but carries significant extrapyramidal risks and isn’t as targeted for anxiolysis as trifluoperazine in this context. And pairing two antipsychotics isn’t a typical or appropriate strategy for short-term anxiety reduction. In sum, trifluoperazine is chosen here for its rapid tranquilizing effect, which aligns with short-term management of generalized anxiety in non-psychotic presentations.

Short-term control of generalized anxiety relies on agents with rapid tranquilizing/sedative effects. Trifluoperazine, a potent phenothiazine, has strong sedative and calming properties due to its dopamine blockade in the limbic system and additional tranquilizing effects (often also through antihistaminic activity). This makes it useful for quick relief of acute anxiety or agitation in non-psychotic states.

The other options don’t fit this purpose as well. A combination of an antipsychotic with an antidepressant isn’t standard for short-term anxiety management and adds unnecessary complexity and side effects. A single high-potency antipsychotic like haloperidol can calm anxiety through sedation but carries significant extrapyramidal risks and isn’t as targeted for anxiolysis as trifluoperazine in this context. And pairing two antipsychotics isn’t a typical or appropriate strategy for short-term anxiety reduction.

In sum, trifluoperazine is chosen here for its rapid tranquilizing effect, which aligns with short-term management of generalized anxiety in non-psychotic presentations.